CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly, the proportion of PD1+CD8+ TEM cells increased in DN-CML (41.90%, P = 0.0006), TKI-F (33.28%, P = 0.0101), Pre-MMR (33.75%, P = 0.0039), and even MMR (29.56%, P = 0.0101) patients compared with HIs (20.08%).